Eddie Moradian, PhD, Chief Executive Officer
Founding of over two-dozen companies over a career spanning nearly 25 years in the healthcare, pharma and biotechnology industry, Eddie Moradian provides MD Biosciences Innovalora with the leadership and management experience needed to forge the path forward. Results- and metrics-oriented as well as process driven in management, he has created companies that have each garnered high respect in their industrial area, from customers, trade partners, as well as collaborators and competitors. This management experience will benefit MD Biosciences Innovalora in its effort to pursue value creation in the most efficient ways and with the participation of collaborators. Eddie Moradian received his PhD in biotechnology in 1991 from the Swiss Federal Institute of Technology in Zurich, Switzerland and is a member of various leading industrial organizations.
Sigal Meilin, PhD, Chief Scientific Officer
Sigal Meilin has spent over two decades in the pharmaceutical industry in Director/Leadership positions such as Head of Preclinical Development at Pharmos Corporation. At Pharmos, Sigal Meilin lead the company's effort in the development of early stage therapeutics. In 2006, she joined MD Biosciences where her career spanned most of the last decade in the development of propietary and novel disease models as well as highly informative studies for corporate research sponsors. These activities contributed greatly towards the value of compounds and subsequently that of sponsor partners. Major contributions included the development of Senerga® Phenotypic Screening Platform as well as translational disease models for a variety of diseases. Sigal Meilin is a highly respected neuroscientist and a regularly invited speaker and presenter at industry-specific meetings and major conferences such as the yearly Society for Neurology congress. Sigal Meilin earned her PhD from Bar Ilan University.